Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Intranasal ketamine for moderate to severe pain in children- a dose finding study.


To see complete record on anzctr.org.au, please visit this link

Id: ACTRN12612000012875

Organisation Name: Southern Health

Overal Status: Completed

Start Date: 24/02/2012

Brief Summary: This study aims ot assess the effectiveness of ketamine as an pain reliever when administered into the nasal passages in doses that do not produce sedation or anaesthesia in a group of paediatric emergency department patients coming to hospital with moderate to severe pain.

We hypothesise that ketamine will reduce pain effectively without significant sedation at the proposed dose.

The data from this study will be used to calculate sample size and design a study comparing the effective dose of ketamine to other pain relivers currently administered by the nasal route to children.

Countries:
  • Australia
Conditions:
  • acute pain
  • musculoskeletal injury


Total execution time in seconds: 0.16252398490906